MPH Health Care AG
XETRA:93M1

Watchlist Manager
MPH Health Care AG Logo
MPH Health Care AG
XETRA:93M1
Watchlist
Price: 22.6 EUR -1.74% Market Closed
Market Cap: 96.8m EUR
Have any thoughts about
MPH Health Care AG?
Write Note

MPH Health Care AG
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MPH Health Care AG
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
MPH Health Care AG
XETRA:93M1
Capital Expenditures
-€4.7k
CAGR 3-Years
-2%
CAGR 5-Years
16%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Capital Expenditures
-$590k
CAGR 3-Years
-114%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Capital Expenditures
-€2.7B
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Merck KGaA
XETRA:MRK
Capital Expenditures
-€2.3B
CAGR 3-Years
-7%
CAGR 5-Years
-17%
CAGR 10-Years
-15%
Dermapharm Holding SE
XETRA:DMP
Capital Expenditures
-€39.7m
CAGR 3-Years
11%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Capital Expenditures
-€866k
CAGR 3-Years
1%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
No Stocks Found

MPH Health Care AG
Glance View

Market Cap
96.8m EUR
Industry
Pharmaceuticals

MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.

93M1 Intrinsic Value
29.77 EUR
Undervaluation 24%
Intrinsic Value
Price

See Also

What is MPH Health Care AG's Capital Expenditures?
Capital Expenditures
-4.7k EUR

Based on the financial report for Dec 31, 2023, MPH Health Care AG's Capital Expenditures amounts to -4.7k EUR.

What is MPH Health Care AG's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
16%

Over the last year, the Capital Expenditures growth was 16%. The average annual Capital Expenditures growth rates for MPH Health Care AG have been -2% over the past three years , 16% over the past five years .

Back to Top